SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $32,320,000 | +1.8% | 2,885,725 | -0.0% | 0.01% | -6.7% |
| Q2 2017 | $31,752,000 | +12.2% | 2,886,532 | -0.0% | 0.02% | +7.1% |
| Q1 2017 | $28,299,000 | -9.3% | 2,887,661 | -0.0% | 0.01% | -12.5% |
| Q4 2016 | $31,198,000 | +5.8% | 2,888,743 | +0.4% | 0.02% | 0.0% |
| Q3 2016 | $29,489,000 | -13.4% | 2,876,992 | +10.3% | 0.02% | -20.0% |
| Q2 2016 | $34,062,000 | +19.0% | 2,608,066 | +0.2% | 0.02% | +17.6% |
| Q1 2016 | $28,634,000 | +21.6% | 2,603,327 | +1.7% | 0.02% | +13.3% |
| Q4 2015 | $23,544,000 | +35.4% | 2,559,182 | +2.2% | 0.02% | +36.4% |
| Q3 2015 | $17,386,000 | -27.9% | 2,505,195 | +2.1% | 0.01% | -26.7% |
| Q2 2015 | $24,103,000 | +10.4% | 2,454,606 | -0.4% | 0.02% | +7.1% |
| Q1 2015 | $21,829,000 | +3.8% | 2,463,781 | +2.7% | 0.01% | 0.0% |
| Q4 2014 | $21,022,000 | +31.0% | 2,399,784 | +3.1% | 0.01% | +27.3% |
| Q3 2014 | $16,043,000 | +32.7% | 2,328,436 | +1.3% | 0.01% | +37.5% |
| Q2 2014 | $12,087,000 | +22.5% | 2,297,884 | +6.0% | 0.01% | +14.3% |
| Q1 2014 | $9,866,000 | -9.4% | 2,168,488 | +0.4% | 0.01% | -12.5% |
| Q4 2013 | $10,891,000 | +0.5% | 2,160,804 | +1.1% | 0.01% | -11.1% |
| Q3 2013 | $10,832,000 | +5.8% | 2,136,518 | +3.5% | 0.01% | -10.0% |
| Q2 2013 | $10,238,000 | – | 2,064,053 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|